- Leads the clusters’ commercial growth strategy for the diverse portfolio, with a very strong focus on the New Portfolio (Hepatitis C and Immuno-Oncology)
- Act as Chief of Staff for the LATAM VP
- Drives all Opdivo launches in the region (Lung, Melanoma, Renal, Head and Neck, , Bladder, Lymphoma, etc.)
- In charge of Commercial Excellence and Patient Support and Disease Testing Areas for the region
- Manage 4 direct reports at a Regional level. Total headcount 18

- Transferred GSK Oncology business and team to Novartis after completion of Novartis/GSK 3-part transaction whereby Novartis acquired the Global Oncology Franchise of GSK

- Leads the oncology franchise in the region
- Influences key internal stakeholders in the countries to ensure sound investments (structure- profile-training) that optimize growth and result in successful new products and indications launches
- Drives multiple launches for new GSK oncology assets and indications including XGEVA, Arzerra in CLL, Tykerb dual blockade in Breast, Revolade in HCV and Tafinlar for melanoma

- Directed marketing activities for Afinitor, Sandostatin LAR, and SOM 230
- Led the regional effort to launch and maximize SAS LAR NET oncology indication, driving the creation and implementation of educational initiatives and diagnosis programs
-Led the launch readiness for Afinitor Breast indication

- Directed marketing activities for Glivec and Sandostatin LAR
- Enabled first launch of oncology SAS LAR NET indication (PROMID) achieving top regional sales growth ~40% and creating and implementing diagnosis programs to facilitate access and diagnosis for ACRO & NET patients
- Implemented educational initiatives with national NET& GIST groups

- Accelerated and enhanced the inclusion of medicines in Formularies (National and HMOs)
- Developed and led relationships with Government officials, key Public and Private Health Institutions
- Represented the company at the Pharmaceutical Chamber (CAEME)
- Developed access programs in partnership with patient groups to facilitate diagnosis and treatment
- Led relationship with Patients Associations